Physical Exercise Prehabilitation Program in MEtabolic SuRgery
NCT ID: NCT06889207
Last Updated: 2025-03-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
58 participants
INTERVENTIONAL
2022-03-14
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Does a supervised exercise program lead to improved physical condition prior to bariatric surgery?
* Does a supervised exercise program prior to bariatric surgery lead to reduced surgery related complications?
* Does a supervised exercise program prior to bariatric surgery lead to maintained lifestyle changes after surgery?
Participants will:
* Receive either no training program or physical exercise training program twice a week, supervised by a physical therapist, for a duration of 8 weeks.
* Have their fitness measured at the start and at the end of the 8 weeks, measured with a six minute walking test.
* Fill in a survey on their perceived quality of life and exercise habits at the start of the trial, and at 1 year after surgery.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prehabilitation for Patients Awaiting Liver Transplantation
NCT05237583
Pre-habilitation Program for Elective Coronary Artery Bypass Graft Surgery Patients
NCT01914094
Pre-operative Rehabilitation for Reduction of Hospitalization After Coronary Bypass and Valvular Surgery.
NCT02219815
Preoperative Excercise Training for Patients Undergoing Coronary Artery Bypass Graft Surgery
NCT04111744
Preoperative Prehabilitation in Patients Planned for Liver Transplantation
NCT06808945
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Prehabilitation
Patients in the intervention group will have two supervised training sessions per week for eight weeks in group sessions supervised by a physiotherapist.
Physical exercise prehabilitation
Patients in the intervention group will have two supervised training sessions per week for eight weeks in group sessions supervised by a physiotherapist.
No prehabilitation
Receives no exercise prehabilitation program
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physical exercise prehabilitation
Patients in the intervention group will have two supervised training sessions per week for eight weeks in group sessions supervised by a physiotherapist.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body-Mass-Index (BMI) 40 kg/m2 or higher, or 35 kg/m2 or higher with the presence of at least one comorbidity (type 2 diabetes, high blood pressure, heart and/or vascular diseases, obstructive sleep apnea (OSA), dyslipidemia, or arthritis).
* Primary bariatric patients; without previous bariatric surgery. For inclusion the investigators will follow the National Guidelines on metabolic surgery.
Exclusion Criteria
* mobility problems (patients who are not able to exercise)
* cognitive disabilities
* illiteracy (patients who are not able to read and understand the language of the country where the study will be performed)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Flevoziekenhuis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
FlevoZiekenhuis
Almere Stad, Flevoland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL74088.018.20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.